Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses' Health Study

被引:485
作者
Parker, William H. [1 ]
Broder, Michael S.
Chang, Eunice
Feskanich, Diane
Farquhar, Cindy
Liu, Zhimae
Shoupe, Donna
Berek, Jonathan S.
Hankinson, Susan
Manson, JoAnn E.
机构
[1] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Obstet & Gynecol, Santa Monica, CA 90401 USA
关键词
CARDIOVASCULAR MORTALITY; POSTMENOPAUSAL WOMEN; LIFE EXPECTANCY; HORMONE-THERAPY; EARLY MENOPAUSE; HEART-DISEASE; RISK; CANCER; OOPHORECTOMY; EXPOSURE;
D O I
10.1097/AOG.0b013e3181a11c64
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To report long-term health outcomes and mortality after oophorectomy or ovarian conservation. METHODS: We conducted a prospective, observational study of 29,380 women participants of the Nurses' Health Study who had a hysterectomy for benign disease; 16,345 (55.6%) had hysterectomy with bilateral oophorectomy, and 13,035 (44.4%) had hysterectomy with ovarian conservation. We evaluated incident events or death due to coronary heart disease (CHD), stroke, breast cancer, ovarian cancer, lung cancer, colorectal cancer, total cancers, hip fracture, pulmonary embolus, and death from all causes. RESULTS: Over 24 years of follow-up, for women with hysterectomy and bilateral oophorectomy compared with ovarian conservation, the multivariable hazard ratios (HRs) were 1.12 (95% confidence interval [CI] 1.03-1.21) for total mortality, 1.17 (95% CI 1.02-1.35) for fatal plus nonfatal CHD, and 1.14 (95% CI 0.98-1.33) for stroke. Although the risks of breast (HR 0.75, 95% CI 0.68-0.84), ovarian (HR 0.04, 95% CI 0.01-0.09, number needed to treat = 220), and total cancers (HR 0.90, 95% CI 0.84-0.96) decreased after oophorectomy, lung cancer incidence (HR = 1.26, 95% CI 1.02-1.56, number needed to harm = 190), and total cancer mortality (HR = 1.17, 95% CI 1.04-1.32) increased. For those never having used estrogen therapy, bilateral oophorectomy before age 50 years was associated with an increased risk of all-cause mortality, CHD, and stroke. With an approximate 35-year life span after surgery, one additional death would be expected for every nine oophorectomies performed. CONCLUSION: Compared with ovarian conservation bilateral oophorectomy at the time of hysterectomy for benign disease is associated with a decreased risk of breast and ovarian cancer but an increased risk of all-cause mortality, fatal and nonfatal coronary heart disease, and lung cancer. in no analysis or age group was oophorectomy associated with increased survival.
引用
收藏
页码:1027 / 1037
页数:11
相关论文
共 29 条
  • [1] *AG HEALTHC RES QU, 2003, HEALTHC COST UT PROJ
  • [2] [Anonymous], 2008, Obstetrics and Gynecology, V111, P231
  • [3] Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations:: A decision analysis
    Armstrong, K
    Schwartz, JS
    Randall, T
    Rubin, SC
    Weber, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) : 1045 - 1054
  • [4] Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis
    Atsma, F
    Bartelink, MLEL
    Grobbee, DE
    van der Schouw, YT
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (02): : 265 - 279
  • [5] Cheung L P, 1998, Climacteric, V1, P33, DOI 10.3109/13697139809080679
  • [6] REPRODUCIBILITY AND VALIDITY OF SELF-REPORTED MENOPAUSAL STATUS IN A PROSPECTIVE COHORT STUDY
    COLDITZ, GA
    STAMPFER, MJ
    WILLETT, WC
    STASON, WB
    ROSNER, B
    HENNEKENS, CH
    SPEIZER, FE
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (02) : 319 - 325
  • [7] The Nurses' Health Study: 20-year contribution to the understanding of health among women
    Colditz, GA
    Manson, JE
    Hankinson, SE
    [J]. JOURNAL OF WOMENS HEALTH, 1997, 6 (01) : 49 - 62
  • [8] MENOPAUSE AND THE RISK OF CORONARY HEART-DISEASE IN WOMEN
    COLDITZ, GA
    WILLETT, WC
    STAMPFER, MJ
    ROSNER, B
    SPEIZER, FE
    HENNEKENS, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (18) : 1105 - 1110
  • [9] Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc
    Cramer, Daniel W.
    Welch, William R.
    Berkowitz, Ross S.
    Godleski, John J.
    [J]. OBSTETRICS AND GYNECOLOGY, 2007, 110 (02) : 498 - 501
  • [10] Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer
    Cramer, DW
    Titus-Ernstoff, L
    McKolanis, JR
    Welch, WR
    Vitonis, AF
    Berkowitz, RS
    Finn, OJ
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (05) : 1125 - 1131